SLC7A5 and cancer: Kaneda-Nakashima et al. in Osaka University prepared 211At-labeled α-methyl-L-tyrosine (211At-AAMT) targeting a cancer-specific L-type amino acid transporter 1 (LAT1), which is highly expressed in cancer cells, but rarely expressed in normal cells [11].